| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,556 |
4,675 |
$281K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,037 |
2,538 |
$242K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,830 |
1,309 |
$125K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,546 |
1,276 |
$117K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,093 |
2,587 |
$109K |
| 96127 |
|
5,954 |
4,607 |
$98K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
896 |
785 |
$67K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,418 |
2,743 |
$62K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
697 |
574 |
$57K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,789 |
1,616 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,828 |
1,077 |
$36K |
| 96160 |
|
1,624 |
1,342 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,757 |
1,435 |
$27K |
| 87428 |
|
421 |
347 |
$27K |
| Q3014 |
Telehealth originating site facility fee |
446 |
234 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
380 |
326 |
$10K |
| 99173 |
|
982 |
882 |
$7K |
| 0071A |
|
140 |
131 |
$6K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
372 |
319 |
$5K |
| 90686 |
|
307 |
279 |
$5K |
| 90651 |
|
283 |
238 |
$5K |
| 83655 |
|
398 |
289 |
$5K |
| 0072A |
|
109 |
108 |
$5K |
| 90677 |
|
263 |
160 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
89 |
61 |
$4K |
| 90656 |
|
219 |
215 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
278 |
250 |
$3K |
| 36416 |
|
793 |
625 |
$3K |
| 90670 |
|
179 |
165 |
$3K |
| 85018 |
|
1,219 |
906 |
$3K |
| 90633 |
|
142 |
99 |
$2K |
| 90680 |
|
139 |
117 |
$2K |
| 90698 |
|
123 |
118 |
$2K |
| 94760 |
|
678 |
570 |
$2K |
| 99000 |
|
82 |
77 |
$1K |
| 90619 |
|
75 |
61 |
$1K |
| 90744 |
|
59 |
58 |
$985.89 |
| 91321 |
|
32 |
27 |
$534.72 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
28 |
27 |
$342.94 |
| 90621 |
|
19 |
14 |
$317.49 |
| 90697 |
|
13 |
12 |
$217.23 |
| 90710 |
|
13 |
12 |
$217.23 |
| 3008F |
|
168 |
160 |
$0.00 |
| 1220F |
|
83 |
44 |
$0.00 |
| 1036F |
|
112 |
71 |
$0.00 |
| 96161 |
|
68 |
67 |
$0.00 |
| 3351F |
|
73 |
40 |
$0.00 |
| 1003F |
|
466 |
323 |
$0.00 |
| 3210F |
|
494 |
379 |
$0.00 |
| 4274F |
|
351 |
200 |
$0.00 |
| 99072 |
|
354 |
283 |
$0.00 |